Survival benefit of tofacitinib in interstitial lung disease associated with anti-MDA5-positive dermatomyositis: a need for further validation

Chih-Wei Tseng^{1

2}, James Cheng-Chung Wei^{3

4

5}

Affiliations

¹ Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
² Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
³ Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan jccwei@gmail.com.
⁴ Department of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
⁵ Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.

Comment

Chih-Wei Tseng et al. Eur Respir J. 2025.

. 2025 Jul 14;66(1):2500306.

doi: 10.1183/13993003.00306-2025. Print 2025 Jul.

Chih-Wei Tseng^{1

2}, James Cheng-Chung Wei^{3

4

5}

¹ Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
² Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
³ Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan jccwei@gmail.com.
⁴ Department of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
⁵ Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.

No abstract available

Conflict of interest statement

Conflict of interest: The authors declare that they have no relevant competing interests.

Effectiveness and safety of tofacitinib versus calcineurin inhibitor in interstitial lung disease secondary to anti-MDA5-positive dermatomyositis: a multicentre cohort study.
Wu W, Guo B, Sun W, Chen D, Xu W, Chen Z, Fu Y, Ye Y, Lyu X, Xue Z, Wang K, Zhao J, Xie C, Chen Y, Ye C, Dai M, Fan W, Li J, Wang X, Xue Y, Wan W, Sun L, Wu H, Luo Q, Han Q, Fu Q, Ye S. Wu W, et al. Eur Respir J. 2025 May 22;65(5):2401488. doi: 10.1183/13993003.01488-2024. Print 2025 May. Eur Respir J. 2025. PMID: 39884766 Free PMC article.